Chronic Hepatitis B Infection Among Preexposure Prophylaxis Users Enrolled in a Population-Based Program in British Columbia, Canada

Initiation of human immunodeficiency virus preexposure prophylaxis (PrEP) medications will also treat hepatitis B infection (HBV). The prevalence of chronic HBV was 0.86% (n=41/4760) among enrollees in a provincial PrEP program in British Columbia, Canada. Overall, 46.3% lacked follow-up HBV DNA mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Kyle A, Blank, Gabriel, Toy, Junine, Moore, David M, Lachowsky, Nathan, Bacani, Nicanor, Zhang, Wendy, Sereda, Paul, Lima, Viviane D, Barrios, Rolando, Montaner, Julio S G, Hull, Mark W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598915/
https://www.ncbi.nlm.nih.gov/pubmed/34805433
http://dx.doi.org/10.1093/ofid/ofab492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598915/
https://www.ncbi.nlm.nih.gov/pubmed/34805433
http://dx.doi.org/10.1093/ofid/ofab492

Ejemplares similares